Our team is committed to both clinical and basic science research. We are an active participant in the Children's Oncology Group (COG) and currently have a wide variety of open clinical trials available for patients who are interested in participating. We are also a member of the COG Phase I Consortium which gives patients the opportunity to participate in studies with promising new experimental treatments. Click on this link to learn more about our Developmental Therapeutics Program. During consultations with families, we discuss all options to arrive at the best plan of care for the patient.
UAB is one of 8 centers in the U.S. that was awarded membership into the Neurofibromatosis (NF) Consortium sponsored by the Department of Defense. This group will be conducting research studies for problems related to NF including tumors that are associated with this disorder. More information about our NF program and studies can be found at: https://www.uab.edu/nfconsortium/.
UAB is a world leader in basic science brain tumor research and has one of the 4 Brain Tumor SPORE Grants funded by the NIH. This provides critical funding to understand the biology of brain tumors and find better treatment than we currently have. We have funding through the SPORE grant for Dr. Kevin Cassidy.